Huvitz Co., Ltd. (KOSDAQ:065510)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Ophthalmic Medical Device Business			117.74B	-	-	-	-
Manufacturing Business			-	-	100.98B	70.14B	95.58B
Manufacturing Business Growth			-	-	43.97%	-26.62%	11.70%
Financial Investment			-	-	3.28B	7.08B	2.22B
Financial Investment Growth			-	-	-53.67%	218.88%	-10.12%
Connection Adjustment			-	-	-9.24B	-7.13B	-9.82B
Total			117.74B	-	95.02B	70.09B	87.99B
Total Growth			-	-	35.57%	-20.34%	11.57%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Americas			17.33B	16.88B	14.87B	-	-
Americas Growth			2.63%	13.55%	-	-	-
Europe			53.40B	46.94B	38.91B	-	-
Europe Growth			13.77%	20.62%	-	-	-
Asia			43.28B	39.97B	25.02B	-	-
Asia Growth			8.27%	59.79%	-	-	-
Other			3.73B	4.99B	4.07B	-	-
Other Growth			-25.27%	22.59%	-	-	-
South Korea			-	-	12.15B	-	-
Total			117.74B	108.78B	95.02B	-	-
Total Growth			8.23%	14.48%	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error